English  |  正體中文  |  简体中文  |  2831377  
???header.visitor??? :  33279245    ???header.onlineuser??? :  944
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsiao cf"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-25 of 201  (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2024-11-22 Polygenic risk score and lung adenocarcinoma risk among never-smokers by EGFR mutation status-a brief report Blechter, B;Hsiung, CA;Wang, X;Zhang, H;Seow, WJ;Shi, J;Chatterjee, N;Kim, HN;Wong, MP;Hong, YC;Wong, JY;Dai, J;Hosgood, HD;Wang, Z;Chang, IS;Choi, J;Wang, J;Song, M;Hu, W;Zheng, W;Kim, JH;Zhou, B;Albanes, D;Shin, MH;Chung, LP;An, SJ;Zheng, H;Yatabe, Y;Zhang, XC;Kim, YT;Shu, XO;Kim, YC;Vermeulen, RCH;Bassig, BA;Chang, J;Man Ho, JC;Ji, BT;Kubo, M;Daigo, Y;Momozawa, Y;Kamatani, Y;Honda, T;Kunitoh, H;Watanabe, SI;Miyagi, Y;Nakayama, H;Matsumoto, S;Tsuboi, M;Goto, K;Yin, Z;Takahashi, A;Goto, A;Minamiya, Y;Shimizu, K;Tanaka, K;Wu, T;Wei, F;Su, J;Kim, YH;Oh, IJ;Fun Lee, VH;Su, WC;Chen, YM;Chang, GC;Chen, KY;Huang, MS;Lin, HC;Seow, A;Park, JY;Kweon, SS;Chen, CJ;Gao, YT;Wu, C;Qian, B;Lu, D;Liu, J;Jeon, HS;Hsiao, CF;Sung, JS;Tsai, YH;Jung, YJ;Guo, H;Hu, Z;Chen, TY;Burdett, L;Yeager, M;Hutchinson, A;Berndt, SI;Wu, W;Wang, J;Choi, JE;Park, KH;Sung, SW;Liu, L;Kang, CH;Chen, CH;Xu, J;Guan, P;Tan, W;Wang, CL, .;al, et
國家衛生研究院 2024-09-30 Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521 Liao, BC;Chiang, NJ;Chang, GC;Su, WC;Luo, YH;Chong, IW;Yang, TY;Lai, CL;Hsia, TC;Ho, CL;Lee, KY;Hsiao, CF;Ku, FC;Fang, WT;Chih-Hsin Yang, J
國家衛生研究院 2024-08-28 A statistical method for protocol modifications with heterogeneous population variances Chiang, CH;Wu, YJ;Cheng, LH;Liu, CT;Hsiao, CF
國家衛生研究院 2024-08-21 Immune killer cells treatment for previously treated stage IV NSCLC patients Tseng, YH;Ho, CL;Chian, CF;Chiang, CL;Chao, HS;Tsai, CL;Perng, WC;Hsiao, CF;Chuang, MH;Ko, KH;Cheng, YC;Chen, SJ;Wang, CJ;Chen, YM
國家衛生研究院 2024-07-11 Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study Tsai, HJ;Shan, YS;Yang, CY;Hsiao, CF;Tsai, CH;Wang, CC;Lin, MT;Ting, CF;Chan, DC;Chen, TH;Yen, CC;Chen, YY;Lin, HY;Yeh, TS;Ho, CL;Shieh, TY;Bai, LY;Hsu, JT;Chen, IS;Chen, LT;Yeh, CN;Liu, TW;Chuang, CH;Wang, TE
國家衛生研究院 2024-06-24 The clinical characteristics and manifestation of anxious depression among patients with major depressive disorders-results from a Taiwan multicenter study Lin, HL;Lee, WY;Liu, CH;Chiang, WY;Hsu, YT;Hsiao, CF;Tsou, HH;Liu, CY
國家衛生研究院 2024-06-21 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study Tsai, HJ;Yang, SH;Hsiao, CF;Kao, HF;Su, YY;Shan, YS;Yen, CJ;Du, JS;Hsu, C;Wu, IC;Chen, LT
國家衛生研究院 2023-11-13 Polygenic risk score, environmental tobacco smoke, and risk of lung adenocarcinoma in never-smoking women in Taiwan Blechter, B;Chien, LH;Chen, TY;Chang, IS;Choudhury, PP;Hsiao, CF;Shu, XO;Wong, JYY;Chen, KY;Chang, GC;Tsai, YH;Su, WC;Huang, MS;Chen, YM;Chen, CY;Hung, HH;Hu, JW;Shi, J;Zheng, W;Rositch, AF;Chen, CJ;Chatterjee, N;Yang, PC;Rothman, N;Hsiung, CA;Lan, Q
國家衛生研究院 2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Su, YY;Lin, YJ;Hsiao, CF;Ou, DL;Chen, SC;Wang, HW;Wang, JH;Wu, YM;Lee, WC;Chou, SC;Ho, CL;Chiu, CF;Chen, LT;Shen, YS;Cheng, AL;Hsu, C
國家衛生研究院 2023-11 The registry of genetic alterations of Taiwan NSCLC by comprehensive next-generation sequencing: A real-world cohort study - TCOG T1521 study Liao, BC;Chiang, NJ;Chang, GC;Su, WC;Chong, IW;Yang, TY;Luo, YH;Lai, CL;Hsia, TC;Ho, CL;Lee, KY;Hsiao, CF;Yang, JCH
國家衛生研究院 2023-01-10 Bayesian hierarchical models for adaptive basket trial designs Chen, C;Hsiao, CF
國家衛生研究院 2022-11 BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma Chiang, NJ;Hung, YP;Lien, MY;Wu, SY;Chang, WL;Bai, LY;Hsiao, CF;Chen, SH;Wu, IC;Chen, MH
國家衛生研究院 2022-09-21 Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan Chien, LH;Chen, TY;Chen, CH;Chen, KY;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Huang, MS;Chen, YM;Chen, CY;Liang, SK;Chen, CY;Wang, CL;Hung, HH;Jiang, HF;Hu, JW;Rothman, N;Lan, Q;Liu, TW;Chen, CJ;Yang, PC;Chang, IS;Hsiung, CA
國家衛生研究院 2022-07-18 Impaired chromatin remodeling predicts survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract cancer: A phase II T1219 study Chiang, NJ;Tan, KT;Bai, LY;Hsiao, CF;Huang, CY;Hung, YP;Huang, CJ;Chen, SC;Shan, YS;Chao, Y;Huang, YH;Lee, IC;Lee, PC;Su, YY;Chen, SJ;Yeh, CN;Chen, LT;Chen, MH
國家衛生研究院 2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Chen, MH;Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, LT
國家衛生研究院 2022-06-02 Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma Su, YY;Liu, YS;Hsiao, CF;Hsu, C;Chen, LT
國家衛生研究院 2022-05-02 Three-stage pooled plasma hepatitis C virus RNA testing for the identification of acute HCV infections in at-risk populations Sun, HY;Chiang, C;Huang, SH;Guo, WJ;Chuang, YC;Huang, YC;Yang, CJ;Su, LH;Chen, YT;Chen, YW;Hsu, FC;Ho, SY;Liu, WC;Su, YC;Chang, SY;Hsiao, CF;Hung, CC;Yu, ML
國家衛生研究院 2022-01 Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients Blanchard, P;Lee, AWM;Carmel, A;Wai Tong, N;Ma, J;Chan, ATC;Hong, RL;Chen, MY;Chen, L;Li, WF;Huang, PY;Kwong, DLW;Poh, SSX;Ngan, R;Mai, HQ;Ollivier, C;Fountzilas, G;Zhang, L;Bourhis, J;Aupérin, A;Lacas, B;Pignon, JP;Benhamou, E;Chakrabandhu, S;Tc Chan, A;Chen, QY;Chen, Y;Chappell, RJ;Choi, H;Tt Chua, D;Lee Kiang Chua, M;Higgins, J;Hong, MH;Hong, RL;Pun Hui, E;Hsiao, CF;Kam, M;Angeliki Koliou, G;Lw Kwong, D;Lai, SC;On Lam, K;LeBlanc, ML;Wm Lee, A;Fun Victor Lee, H;Fei Li, W;Ma, B;Mo, F;Moon, J;Tong Ng, W;O'Sullivan, B;Petit, C;Pierre Pignon, J;Poh, SX;Rücker, G;Sham, J;Lim Soong, Y;Sun, Y;Tan, T;Tang, LQ;Tung, Y;Wee, J;Wu, X;Xu, T;Zhang, Y;Zhu, G;on behalf of the MACNPCcG
國家衛生研究院 2021-11-12 The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience Tsai, HJ;Hsiao, CF;Chang, JS;Chen, LT;Chao, YJ;Yen, CJ;Shan, YS
國家衛生研究院 2021-10-27 Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances Wu, YJ;Cheng, YC;Chiang, C;Cheng, LH;Liu, CT;Hsiao, CF
國家衛生研究院 2021-09-27 Comment on"Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment": Is real-world evidence real? Chen, C;Hsiao, CF
國家衛生研究院 2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, L;Chen, MH
國家衛生研究院 2021-05 High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ
國家衛生研究院 2021-05 A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy Bai, LY;Yang, MH;Chiang, NJ;Wu, SY;Lin, CY;Lien, MY;Chen, JH;Chang, MH;Hsieh, CY;Hong, RL;Kao, HF;Ye, RH;Chen, SH;Hsiao, CF;Chen, LT;Liu, TW
國家衛生研究院 2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma Chiang, NJ;Shan, YS;Bai, LY;Li, CP;Chen, JS;Yang, SH;Kuo, YC;Chao, Y;Hsieh, YY;Kao, HF;Hsiao, CF;Chen, LT

Showing items 1-25 of 201  (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page